Showing results (51-60 of 84) with videos related to
Sort By:
Pageof 9
Neuropharmacology|July 1, 1992
The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonistJ Maj, Z Rogóz, G Skuza, et al.Polish Journal of Pharmacology and Pharmacy|January 1, 1987
Some central effects of tiflucarbine, a new potential antidepressant drugJ Maj, Z Rogóz, H Sowińska, et al.Polish Journal of Pharmacology and Pharmacy|July 1, 1989
The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in miceJ Maj, Z Rogóz, G Skuza, et al.Polish Journal of Pharmacology and Pharmacy|January 1, 1983
The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in miceJ Maj, Z Rogóz, G Skuza, et al.Polish Journal of Pharmacology|July 1, 1995
Some behavioral effects of CNQX AND NBQX, AMPA receptor antagonistsJ Maj, Z Rogóz, G Skuza, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
Antidepressant effects of pramipexole, a novel dopamine receptor agonistJ Maj, Z Rogóz, G Skuza, et al.Journal of Neural Transmission|January 1, 1984
Repeated treatment with antidepressant drugs increases the behavioural response to apomorphineJ Maj, Z Rogóz, G Skuza, et al.European Journal of Pharmacology|April 11, 1997
The behavioural effects of pramipexole, a novel dopamine receptor agonistJ Maj, Z Rogóz, G Skuza, et al.Journal of Neural Transmission. General Section|January 1, 1989
Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonistJ Maj, Z Rogóz, G Skuza, et al.Polish Journal of Pharmacology|May 19, 2000
Pharmacological profile of reboxetine, a representative of new class of antidepressant drugs, selective noradrenaline reuptake inhibitor (NARI), given acutelyZ Rogóz, A Wróbel, M Krasicka-Domka, et al.Pageof 9